China Atopic Dermatitis Registry Study

Last updated: August 20, 2021
Sponsor: Peking University People's Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Allergy

Dermatitis, Atopic

Atopic Dermatitis

Treatment

N/A

Clinical Study ID

NCT05023668
SGZ-2020-12888
  • Ages > 12
  • All Genders

Study Summary

This regestry study is aimed to characterize the medical care and drug treatment under real-life conditions among Chinese patients with moderate to severe Atopic Dermatitis who are not well controlled by topical therapies.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age≥12;
  • AD according to Williams diagnosis criteria (see Appendix 1);
  • Moderate to severe AD that inadequately controlled by topical therapy
  • Moderate-to-severe: SCORAD score≥25; or
  • Inadequately controlled by topic therapies: Determined by physicians.

Exclusion

Exclusion Criteria:

  • No.

Study Design

Total Participants: 10000
Study Start date:
July 28, 2021
Estimated Completion Date:
October 31, 2024

Study Description

Atopic dermatitis (AD) is a chronic recurrent inflammatory skin disease, resulting in itchy, red, and skin lesion. A survey conducted in 2014 in 39 tertiary hospitals of 15 provinces in mainland China has shown that the incidence of AD in outpatients (7.8%) has been raised in recent years.

Among topical therapy of AD, corticosteroids are first line therapy. In patients with extensive and severe dermatitis, topical therapy may be insufficient. Such patients may require the addition of either oral corticosteroid or systemic immunosuppressive therapy and even phototherapy. There is no clear recommendation treatment for each kind of patients with different severity yet and there are still huge unmet medical needs for treatment. There is not clear recommendation grade for these therapy in Chinese AD guideline and no published data to demonstrate current treatment situation in real clinical practise.

The goal of clinical registry study is to document the use and effectiveness of therapeutic interventions under real-life conditions. This study will help understand the clinical characteristics, treatment utilization, treatment patterns, as well as disease-related outcomes and cost among AD patients in China.

Connect with a study center

  • Peking University People's Hospital

    Beijing, Beijing 100044
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.